Allogene Therapeutics, Inc. (ALLO)
收市後：
| 前收市價 | 3.3700 |
| 開市 | 3.3700 |
| 買盤 | 3.0000 x 600 |
| 賣出價 | 3.0700 x 400 |
| 今日波幅 | 3.0300 - 3.4200 |
| 52 週波幅 | 2.2300 - 6.8900 |
| 成交量 | |
| 平均成交量 | 2,282,691 |
| 市值 | 518.998M |
| Beta 值 (5 年，每月) | 0.80 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -2.0900 |
| 業績公佈日 | 2024年5月01日 - 2024年5月06日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 9.69 |
ZacksAllogene Therapeutics (ALLO) Expected to Beat Earnings Estimates: Should You Buy?
Allogene Therapeutics (ALLO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
InvestorPlace3 Meme Stocks to Sell and Replace With Meme Coins
Social media has largely overshadowed the investing fundamentals with pumpamentals, spotlighting meme stocks to sell. Just as Bitcoin is analog to blue-chip stocks, meme stocks have similarly become analog to altcoins. Both are driven by narratives fed by short-term valuation surges. But, just as easily as they went up, meme stocks can go down. Pitting their float shorted against dwindling revenue figures and rapid cash depletion, which meme stocks should be ousted from your speculative portfoli
ZacksHow Allogene (ALLO) Stock Stands Out in a Strong Industry
Allogene (ALLO) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
